Co-Authors
This is a "connection" page, showing publications co-authored by Giovanni Scambia and Marco Di Maio.
Connection Strength
0.070
-
Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer. Crit Rev Oncol Hematol. 2018 Sep; 129:54-66.
Score: 0.048
-
Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trial. BMC Cancer. 2006 Aug 01; 6:202.
Score: 0.021